What 'scattered fibroglandular densities' mean on your mammogram report

Every breast is a mix of two things: fatty tissue, and fibroglandular tissue — the fibrous supporting tissue plus the glandular tissue, the lobules and ducts that make and carry milk. On a mammogram, fatty tissue looks dark and fibroglandular tissue looks white. 'Scattered fibroglandular densities,' sometimes written 'scattered areas of fibroglandular density,' means your breasts are mostly fatty, with some scattered patches of that whiter, denser tissue mixed through. The National Cancer Institute defines the phrase as exactly that — breast tissue made up of mostly fatty tissue with some scattered dense fibrous and glandular tissue.

The reframe that takes the fear out of it: this is a description of normal composition, not a finding. It is not a lump, not a mass, not a spot, and not something the radiologist discovered. It is the radiologist describing what your breast tissue is made of, the same way a report might note your build. Everyone is somewhere on this scale, and yours is near the low end of it.

It is also among the most common results there is — roughly four in ten women fall into this category. If you want to read the rest of the report line by line, the companion guides on reading a radiology report and the other reassuring-but-confusing words like 'unremarkable' and 'within normal limits' cover the words you will meet alongside this one.

Breast density is scored on a four-level scale set by the American College of Radiology, from least to most dense. Category A: almost entirely fatty (about 1 in 10 women). Category B: scattered areas of fibroglandular density — yours — (about 4 in 10). Category C: heterogeneously dense (about another 4 in 10). Category D: extremely dense (about 1 in 10). So 'scattered' is category B, the second-lowest rung: one step above almost-entirely-fatty, and two steps below the densest.

Here is the single most useful fact in this guide: only categories C and D are considered 'dense breasts.' A and B are not. The National Cancer Institute labels category B in plain words — 'scattered fibroglandular (not dense).' So if you have been reading that dense breasts are harder to screen and carry higher risk, and worrying that it applies to you, for category B it mostly does not. You are on the not-dense side of the line.

One more thing worth knowing: a radiologist assigns the category by eye, increasingly with software help, so it is partly a judgment call and can shift a little from year to year or reader to reader. Density also tends to decrease with age, as more of the breast becomes fatty. A 'scattered' reading this year may have been 'heterogeneously dense' a decade ago — that drift is normal, not a change to worry about.

The reason you are reading about your density at all is a change in the law, not a change in your body. The FDA published a final rule amending the Mammography Quality Standards Act in March 2023, and since September 10, 2024, every mammography facility in the United States has been required to tell you, in plain language, whether your breasts are 'dense' or 'not dense.' Before that it was a patchwork — roughly 38 states had their own notification laws, and the rest had none.

For the patient letter, the four categories collapse into two buckets: A and B are reported to you as 'not dense,' and C and D as 'dense.' Because scattered fibroglandular densities is category B, your letter says your breasts are not dense. The standardized wording also explains that dense tissue can make cancer harder to see on a mammogram and slightly raises risk — both true for the dense categories, and the reason the notice exists at all — and then tells you which side of that line you are on.

So the phrase itself is not new and is not a red flag. What changed is the requirement to put your density in front of you. If you are reading this for a parent or partner whose report just started including it, the same is true for them: the letter arrived because of the rule, not because anything was found.

This is the part almost no one explains, and it is the one that matters most. Your mammogram report carries two separate scores. One is the density category you have been decoding, A through D — a description of what your breast tissue is made of. The other is the BI-RADS assessment category, a number from 0 to 6, and that number is the radiologist's actual bottom line: whether they saw anything that needs attention. The letter describes your tissue; the number is the verdict.

The numbers, briefly: 0 means the read is incomplete and they need more images; 1 means negative — nothing to see; 2 means a benign, harmless finding such as a simple cyst; 3 means probably benign, with a short-interval follow-up just to be safe; 4 means suspicious enough to recommend a biopsy; 5 means highly suggestive of cancer; and 6 is reserved for an already-confirmed cancer. For a routine screening mammogram, the large majority of reports come back a 1 or a 2.

So a report that reads 'scattered fibroglandular densities, BI-RADS category 1' is telling you two reassuring things at once: your breasts are not dense, and the radiologist saw nothing concerning. When you scan your report, find the assessment number first — that is the answer to the question you are actually asking. The density letter is context around it. The guide on reading a radiology report walks through where both sit on the page.

The honest version: scattered fibroglandular densities is good news, and it is not cancer. It cannot 'turn into' cancer, because it is not a growth or an abnormality — it is the normal makeup of your breast tissue. There is nothing to treat and it causes no symptoms. Searches for 'symptoms of fibroglandular density' or 'fibroglandular tissue treatment' are looking for something that does not exist; there is no condition here to have symptoms or need treating.

There is one honest nuance, because density is a continuum and not a switch. Breast density does carry some association with breast-cancer risk, and even category B sits a little above almost-entirely-fatty breasts on that scale — meaningfully above the lowest category, though well below the dense ones. A large 2022 analysis found that women with extremely dense breasts have roughly double the breast-cancer risk of women with scattered density. The takeaway is not that your risk is zero — no one's is — but that you are on the lower, more favorable, easier-to-read end of the range.

And the masking worry you may have read about — dense tissue is white, tumors are white, so dense tissue can hide them — is real, but it is a concern for the dense categories, C and D, where there is enough white tissue to hide something. With scattered density your breasts are mostly fatty and dark, so a mammogram sees through them well. That is exactly why category B counts as 'not dense.'

For category B, on the strength of density alone: not really. Your mammogram remains a good test for you, and density does not change the recommended schedule — the U.S. Preventive Services Task Force recommends a screening mammogram every two years from age 40 to 74, and a 'not dense' result neither shortens nor lengthens that. Your own doctor may suggest a different rhythm based on your personal risk, but the density reading itself is not the reason.

The extra tests you may have read about — a supplemental ultrasound or breast MRI — are aimed at the dense categories, and even there the evidence is genuinely unsettled. The Task Force currently says there is not enough evidence to recommend for or against them: they catch some additional cancers, but they also drive more false alarms and biopsies, and no study has yet shown they save lives. For scattered fibroglandular densities, none of that is triggered by your density. If a doctor ever does suggest more imaging for you, it will be because of other risk factors — a strong family history, a genetic result, prior chest radiation — not because of the word "scattered" on your report.

The throughline: a category-B reading is a reason to keep up your regular mammograms, not a reason to add tests or to lie awake. Read it alongside your BI-RADS number and your personal risk, with your doctor.

Most of the time, 'scattered fibroglandular densities' is exactly what it sounds like once it is translated — a normal, common, reassuring line — and the right first move is to exhale. Then do three small things: note your density letter (you are a B, 'not dense'), find your BI-RADS assessment number (for a routine mammogram, almost always a 1 or 2), and keep the report somewhere you can set it beside next year's, since density drifts with age and a result means more as part of a trend than as a single snapshot.

Two questions are worth bringing to your doctor, and they take a minute: 'What was my BI-RADS assessment category?' and 'Given my family history and personal risk, does anything change for me, or do we stay on the regular mammogram schedule?' Those turn a frightening phrase into a clear, settled answer instead of a week of worrying.

This is the part KeptWell was built for. Upload a mammogram report and it is read and explained in plain English — the phrase you are stuck on decoded, the exact line it came from cited, and never a diagnosis. Because these are medical records, they stay private to your circle: we will not sell them, show ads against them, or train AI on them, ever. Kept in one organized place, this year's report sits next to last year's, so you can see whether anything actually changed. If you are doing this for an aging parent from another city, having it all in one shared place is often the only way the whole family stays on the same page.